Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,095.00
+20.00 (0.49%)
At close: Apr 28, 2026

Kangstem Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
385,152218,206113,229133,971109,830124,057
Upgrade
Market Cap Growth
192.39%92.71%-15.48%21.98%-11.47%-36.85%
Upgrade
Enterprise Value
356,398199,99595,018129,76185,183115,828
Upgrade
Last Close Price
4095.002320.001689.512003.152103.332375.78
Upgrade
PS Ratio
107.8161.0814.6210.556.7410.00
Upgrade
PB Ratio
5.583.162.622.672.081.74
Upgrade
P/TBV Ratio
7.384.182.682.822.271.85
Upgrade
EV/Sales Ratio
99.7655.9812.2710.215.239.34
Upgrade
Debt / Equity Ratio
0.140.140.200.270.250.20
Upgrade
Net Debt / Equity Ratio
-0.42-0.42-0.23-0.47-0.44-0.60
Upgrade
Net Debt / EBITDA Ratio
1.911.910.851.261.402.26
Upgrade
Net Debt / FCF Ratio
2.362.360.501.331.191.97
Upgrade
Asset Turnover
0.050.050.110.160.180.13
Upgrade
Inventory Turnover
3.263.264.7621.1618.5717.37
Upgrade
Quick Ratio
4.754.752.922.072.733.38
Upgrade
Current Ratio
5.255.253.692.553.223.80
Upgrade
Return on Equity (ROE)
-18.65%-18.65%-15.18%-45.17%-32.55%-36.40%
Upgrade
Return on Assets (ROA)
-16.06%-16.06%-13.52%-17.59%-13.99%-15.31%
Upgrade
Return on Capital Employed (ROCE)
-24.10%-24.10%-30.80%-36.40%-31.00%-26.40%
Upgrade
Earnings Yield
-2.72%-4.80%-6.77%-16.38%-18.43%-17.21%
Upgrade
FCF Yield
-3.20%-5.65%-17.29%-13.35%-17.82%-17.43%
Upgrade
Buyback Yield / Dilution
-53.92%-23.10%-38.90%-7.02%-36.23%-24.89%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.